Abstract
Advances in HIV-1 envelope glycoprotein (Env) design generate native-like trimers and high-resolution clade A, B, and G structures and elicit neutralizing antibodies. However, a high-resolution clade C structure is critical, as this subtype accounts for the majority of HIV infections worldwide, but well-ordered clade C Env trimers are more challenging to produce due to their instability. Based on targeted glycine substitutions in the Env fusion machinery, we defined a general approach that disfavors helical transitions leading to post-fusion conformations, thereby favoring the pre-fusion state. We generated a stabilized, soluble clade C Env (16055 NFL) and determined its crystal structure at 3.9 Å. Its overall conformation is similar to SOSIP.664 and native Env trimers but includes a covalent linker between gp120 and gp41, an engineered 201-433 disulfide bond, and density corresponding to 22 N-glycans. Env-structure-guided design strategies resulted in multiple homogeneous cross-clade immunogens with the potential to advance HIV vaccine development.
Keywords:
Antibody; Envelope glycoprotein; Glycan shield; HIV; Immunogen; Trimer; Vaccine; bNAb.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Substitution*
-
Antibodies, Neutralizing / chemistry
-
Antibodies, Neutralizing / immunology
-
Antibodies, Neutralizing / metabolism
-
Binding Sites
-
Genotype
-
Glycine / chemistry*
-
Glycine / genetics
-
Glycosylation
-
HIV Antibodies / chemistry
-
HIV Antibodies / immunology
-
HIV Antibodies / metabolism
-
HIV Envelope Protein gp120 / chemistry
-
HIV Envelope Protein gp120 / genetics
-
HIV Envelope Protein gp120 / immunology
-
HIV Envelope Protein gp41 / chemistry
-
HIV Envelope Protein gp41 / genetics
-
HIV Envelope Protein gp41 / immunology
-
HIV-1 / classification
-
HIV-1 / genetics
-
HIV-1 / immunology*
-
Humans
-
Models, Molecular
-
Mutation
-
Protein Binding / immunology
-
Protein Conformation, alpha-Helical*
-
Protein Engineering
-
Protein Multimerization
-
Protein Stability
-
Proteolysis
-
Solubility
-
Structure-Activity Relationship
-
env Gene Products, Human Immunodeficiency Virus / chemistry*
-
env Gene Products, Human Immunodeficiency Virus / genetics
-
env Gene Products, Human Immunodeficiency Virus / immunology*
Substances
-
Antibodies, Neutralizing
-
HIV Antibodies
-
HIV Envelope Protein gp120
-
HIV Envelope Protein gp41
-
env Gene Products, Human Immunodeficiency Virus
-
Glycine